A new study led by investigators from Mass General Brigham has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia. By combining neuroimaging data from ...
Dec 12, 2024
0
22
New research from King's College London and South London and Maudsley NHS Foundation Trust has shown that genetic load for schizophrenia and frequent use of cannabis have independent links to the likelihood of developing ...
Dec 6, 2024
1
100
The chromosomal disorder 22q11.2 deletion syndrome (22q) has emerged as one of the strongest risks for schizophrenia. Scientists at St. Jude Children's Research Hospital identified malformed regions of the cerebellum in laboratory ...
Dec 5, 2024
0
71
Schizophrenia, which is characterized by positive symptoms (e.g., hallucinations and delusions), negative symptoms (diminished emotional expressions or avolition), and cognitive impairments (attention deficits and poor learning ...
Dec 3, 2024
0
19
Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized patients with schizophrenia, according ...
Nov 19, 2024
1
0
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.
Nov 15, 2024
0
2
Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, according to a new study from researchers at ICES, The Ottawa Hospital, University of Ottawa's Department ...
Nov 13, 2024
0
43
Scientists have known for decades that the classic symptoms of schizophrenia, such as jumping to conclusions or difficulty adjusting to new information, can be attributed to poor communication between the cerebral cortex ...
Nov 7, 2024
0
39
A research team has explored the agreement or discrepancy between subjective social cognitive difficulties and actual cognitive impairment. Their study aimed to identify clinical subtypes in patients with schizophrenia, and ...
Oct 29, 2024
0
0
A collaborative study between researchers at the Icahn School of Medicine at Mount Sinai and Harvard Medical School has identified genetic mutations that occur during brain development and may contribute to the development ...
Oct 11, 2024
0
62
